These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hepatitis B genotypes and surface antigen mutants present in Pakistani blood donors. Harris BJ; Holzmayer V; Qureshi H; Khan MA; Khan SA; Salamat N; Jafri S; Brennan CA PLoS One; 2017; 12(6):e0178988. PubMed ID: 28582431 [TBL] [Abstract][Full Text] [Related]
3. Epidemiology of HBV S-gene mutants in the Liguria Region, Italy: Implications for surveillance and detection of new escape variants. Sticchi L; Caligiuri P; Cacciani R; Alicino C; Bruzzone B Hum Vaccin Immunother; 2013 Mar; 9(3):568-71. PubMed ID: 23296324 [TBL] [Abstract][Full Text] [Related]
4. Molecular and serological characterization of hepatitis B virus genotype A and D infected blood donors in Poland. Grabarczyk P; Garmiri P; Liszewski G; Doucet D; Sulkowska E; Brojer E; Allain JP; J Viral Hepat; 2010 Jun; 17(6):444-52. PubMed ID: 19780948 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis B surface antigen variants in voluntary blood donors in Nanjing, China. Yong-Lin Y; Qiang F; Ming-Shun Z; Jie C; Gui-Ming M; Zu-Hu H; Xu-Bing C Virol J; 2012 Apr; 9():82. PubMed ID: 22500577 [TBL] [Abstract][Full Text] [Related]
6. Impact of hepatitis B virus surface protein mutations on the diagnosis of occult hepatitis B virus infection. El Chaar M; Candotti D; Crowther RA; Allain JP Hepatology; 2010 Nov; 52(5):1600-10. PubMed ID: 20815025 [TBL] [Abstract][Full Text] [Related]
7. Molecular and serological evaluation of surface antigen negative hepatitis B virus infection in blood donors from Venezuela. Gutiérrez C; Devesa M; Loureiro CL; León G; Liprandi F; Pujol FH J Med Virol; 2004 Jun; 73(2):200-7. PubMed ID: 15122793 [TBL] [Abstract][Full Text] [Related]
8. Detection of hepatitis B virus DNA among accepted blood donors in Nanjing, China. Liu Y; Li P; Li C; Zhou J; Wu C; Zhou YH Virol J; 2010 Aug; 7():193. PubMed ID: 20718994 [TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of occult hepatitis B cases in Greek blood donors. Katsoulidou A; Paraskevis D; Magiorkinis E; Moschidis Z; Haida C; Hatzitheodorou E; Varaklioti A; Karafoulidou A; Hatzitaki M; Kavallierou L; Mouzaki A; Andrioti E; Veneti C; Kaperoni A; Zervou E; Politis C; Hatzakis A J Med Virol; 2009 May; 81(5):815-25. PubMed ID: 19319945 [TBL] [Abstract][Full Text] [Related]
10. Molecular Epidemiology of Hepatitis B Virus in Turkish Cypriot. Sumer U; Sayan M Pol J Microbiol; 2019 Dec; 68(4):449-456. PubMed ID: 31880889 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus strains from Rwandan blood donors are genetically similar and form one clade within subgenotype A1. Twagirumugabe T; Swaibu G; Walker TD; Lindh M; Gahutu JB; Bergström T; Norder H BMC Infect Dis; 2017 Jan; 17(1):32. PubMed ID: 28056881 [TBL] [Abstract][Full Text] [Related]
12. Detection and molecular characterisation of a diagnosis escape variant associated with occult hepatitis B virus in Brazil. Almeida RW; Mello FCDA; Menegoy IV; Santo MPDE; Ginuíno CF; Sousa PSF; Villar LM; Lampe E; Lewis-Ximenez LL Mem Inst Oswaldo Cruz; 2017 Jul; 112(7):485-491. PubMed ID: 28591309 [TBL] [Abstract][Full Text] [Related]
13. Substantial variation in the hepatitis B surface antigen (HBsAg) in hepatitis B virus (HBV)-positive patients from South Africa: Reliable detection of HBV by the Elecsys HBsAg II assay. Gencay M; Vermeulen M; Neofytos D; Westergaard G; Pabinger S; Kriegner A; Seffner A; Gohl P; Huebner K; Nauck M; Kaminski WE J Clin Virol; 2018 Apr; 101():38-43. PubMed ID: 29414186 [TBL] [Abstract][Full Text] [Related]
14. Diversity of hepatitis B virus infecting Malaysian candidate blood donors is driven by viral and host factors. Meldal BH; Bon AH; Prati D; Ayob Y; Allain JP J Viral Hepat; 2011 Feb; 18(2):91-101. PubMed ID: 20196797 [TBL] [Abstract][Full Text] [Related]
15. Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks. Oluyinka OO; Tong HV; Bui Tien S; Fagbami AH; Adekanle O; Ojurongbe O; Bock CT; Kremsner PG; Velavan TP PLoS One; 2015; 10(7):e0131912. PubMed ID: 26148052 [TBL] [Abstract][Full Text] [Related]
16. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy. Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP; Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857 [TBL] [Abstract][Full Text] [Related]
17. Detection of occult hepatitis B and window period infection among blood donors by individual donation nucleic acid testing in a tertiary care center in South India. Keechilot CS; Shenoy V; Kumar A; Biswas L; Vijayrajratnam S; Dinesh K; Nair P Pathog Glob Health; 2016; 110(7-8):287-291. PubMed ID: 27788631 [TBL] [Abstract][Full Text] [Related]
18. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value? Stramer SL; Zou S; Notari EP; Foster GA; Krysztof DE; Musavi F; Dodd RY Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101 [TBL] [Abstract][Full Text] [Related]